Gupta P C, Sankaranarayanan R, Ferlay J
International Agency for Research on Cancer, Lyon, France.
Bull World Health Organ. 1994;72(6):943-4.
The model-based cancer mortality estimates for India (775,800) are nearly double the data-based estimates (433,000), and are higher than even the incidence estimates (612,300). The model-based approach is therefore, at least in the case of India, incorrect. Established practice is to use real data to validate theoretical models, not to reject the data if apparently the model does not fit.
基于模型的印度癌症死亡率估计数（775,800）几乎是基于数据的估计数（433,000）的两倍，甚至高于发病率估计数（612,300）。因此，至少在印度的案例中，基于模型的方法是不正确的。既定做法是使用真实数据来验证理论模型，而不是在模型明显不适用时就摒弃数据。
